Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,470.33
+523.71(+1.05%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Zelda Therapeutics Limited (ZLDAF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.4800

0.0000

(0.00%)

At close: 01:07PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	5.07M
Enterprise value	6.16M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	28.86
Price/book (mrq)	0.39
Enterprise value/revenue	22.09
Enterprise value/EBITDA	-0.17

Trading information

Stock price history

Beta (5Y monthly)	0.52
52-week change ³	-12.73%
S&P500 52-week change ³	22.38%
52-week high ³	1.6500
52-week low ³	0.4704
50-day moving average ³	0.5146
200-day moving average ³	0.6548

Share statistics

Avg vol (3-month) ³	56
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	11.35M
Implied shares outstanding ⁶	11.86M
Float ⁸	6.16M
% held by insiders ¹	48.71%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:175
Last split date ³	14 Apr 2022

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends	30 Jun 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-5,888.20%

Management effectiveness

Return on assets (ttm)	-17.89%
Return on equity (ttm)	-242.94%

Income statement

Revenue (ttm)	278.89k
Revenue per share (ttm)	0.03
Quarterly revenue growth (yoy)	-28.90%
Gross profit (ttm)	N/A
EBITDA	-5.14M
Net income avi to common (ttm)	-36.43M
Diluted EPS (ttm)	-2.1100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	64.83k
Total cash per share (mrq)	0.01
Total debt (mrq)	1.73M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.43
Book value per share (mrq)	-0.21

Cash flow statement

Operating cash flow (ttm)	-5.38M
Levered free cash flow (ttm)	-545.23k